Journal article
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 5.3MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.bneo.2025.100179
Authors
- Publisher:
- Elsevier
- Journal:
- Blood Neoplasia More from this journal
- Volume:
- 3
- Issue:
- 1
- Publication date:
- 2025-11-07
- Acceptance date:
- 2025-09-29
- DOI:
- EISSN:
-
2950-3280
- ISSN:
-
2950-3280
- Language:
-
English
- Source identifiers:
-
3743478
- Deposit date:
-
2026-02-10
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
If you are the owner of this record, you can report an update to it here: Report update to this record